Press releases
- Harrow to Attend 2024 ASRS Annual Meeting
- Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products
- Harrow Provides TRIESENCE® Relaunch Update
- Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
- Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study
- Harrow to Present at Two Investor Conferences in May
- Harrow Announces First Quarter 2024 Financial Results
- Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
- Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
More ▼
Key statistics
On Tuesday, Harrow Inc (HROWM:NMQ) closed at 26.10, -5.84% below its 52-week high of 27.72, set on Mar 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.11 |
---|---|
High | 26.13 |
Low | 26.10 |
Bid | 25.73 |
Offer | 26.86 |
Previous close | 26.31 |
Average volume | 4.52k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 2.97 USD |
---|---|
Annual div yield (ADY) | 11.28% |
Div ex-date | Jul 15 2024 |
Div pay-date | Jul 31 2024 |
Data delayed at least 15 minutes, as of Jul 23 2024 20:17 BST.
More ▼